85 related articles for article (PubMed ID: 26251444)
1. Novel actions of 2-deoxy-D-glucose: protection against Shiga toxins and changes in cellular lipids.
Kavaliauskiene S; Skotland T; Sylvänne T; Simolin H; Klokk TI; Torgersen ML; Lingelem AB; Simm R; Ekroos K; Sandvig K
Biochem J; 2015 Aug; 470(1):23-37. PubMed ID: 26251444
[TBL] [Abstract][Full Text] [Related]
2. Cellular effects of fluorodeoxyglucose: Global changes in the lipidome and alteration in intracellular transport.
Kavaliauskiene S; Torgersen ML; Lingelem AB; Klokk TI; Lintonen T; Simolin H; Ekroos K; Skotland T; Sandvig K
Oncotarget; 2016 Nov; 7(48):79885-79900. PubMed ID: 27829218
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effect of 2-deoxy-D-glucose on glycoprotein mannosylation in cancer cells.
Ahadova A; Gebert J; von Knebel Doeberitz M; Kopitz J; Kloor M
IUBMB Life; 2015 Mar; 67(3):218-26. PubMed ID: 25854316
[TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum stress (ER-stress) by 2-deoxy-D-glucose (2DG) reduces cyclooxygenase-2 (COX-2) expression and N-glycosylation and induces a loss of COX-2 activity via a Src kinase-dependent pathway in rabbit articular chondrocytes.
Yu SM; Kim SJ
Exp Mol Med; 2010 Nov; 42(11):777-86. PubMed ID: 20926918
[TBL] [Abstract][Full Text] [Related]
5. An Integrated Proteomic and Glycoproteomic Investigation Reveals Alterations in the
Ma C; Tsai HY; Zhang Q; Senavirathna L; Li L; Chin LS; Chen R; Pan S
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897829
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate protection against endothelial cytotoxicity induced by blockade of glucose uptake.
Chung SJ; Lee SH; Lee YJ; Park HS; Bünger R; Kang YH
J Biochem Mol Biol; 2004 Mar; 37(2):239-45. PubMed ID: 15469702
[TBL] [Abstract][Full Text] [Related]
7. Seizure suppression via glycolysis inhibition with 2-deoxy-D-glucose (2DG).
Stafstrom CE; Roopra A; Sutula TP
Epilepsia; 2008 Nov; 49 Suppl 8():97-100. PubMed ID: 19049601
[TBL] [Abstract][Full Text] [Related]
8. Shiga toxins induce autophagy leading to differential signalling pathways in toxin-sensitive and toxin-resistant human cells.
Lee MS; Cherla RP; Jenson MH; Leyva-Illades D; Martinez-Moczygemba M; Tesh VL
Cell Microbiol; 2011 Oct; 13(10):1479-96. PubMed ID: 21722286
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.
Halicka HD; Ardelt B; Li X; Melamed MM; Darzynkiewicz Z
Cancer Res; 1995 Jan; 55(2):444-9. PubMed ID: 7812976
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxyglucose induces cell cycle arrest and apoptosisin colorectal cancer cells independent of its glycolysis inhibition.
Muley P; Olinger A; Tummala H
Nutr Cancer; 2015; 67(3):514-22. PubMed ID: 25751508
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism.
Lin X; Zhang F; Bradbury CM; Kaushal A; Li L; Spitz DR; Aft RL; Gius D
Cancer Res; 2003 Jun; 63(12):3413-7. PubMed ID: 12810678
[TBL] [Abstract][Full Text] [Related]
12. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
13. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
[TBL] [Abstract][Full Text] [Related]
14. 2-Deoxy-d-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic cancer cells.
Ishino K; Kudo M; Peng WX; Kure S; Kawahara K; Teduka K; Kawamoto Y; Kitamura T; Fujii T; Yamamoto T; Wada R; Naito Z
Biochem Biophys Res Commun; 2018 Jun; 501(3):668-673. PubMed ID: 29753740
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin.
Sood A; Mathew R; Trachtman H
Biochem Biophys Res Commun; 2001 Apr; 283(1):36-41. PubMed ID: 11322764
[TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
Zhang D; Li J; Wang F; Hu J; Wang S; Sun Y
Cancer Lett; 2014 Dec; 355(2):176-83. PubMed ID: 25218591
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses.
Lee MS; Cherla RP; Tesh VL
Toxins (Basel); 2010 Jun; 2(6):1515-35. PubMed ID: 22069648
[TBL] [Abstract][Full Text] [Related]
19. Identification of the determinants of 2-deoxyglucose sensitivity in cancer cells by shRNA library screening.
Kobayashi H; Nishimura H; Matsumoto K; Yoshida M
Biochem Biophys Res Commun; 2015 Nov; 467(1):121-7. PubMed ID: 26403972
[TBL] [Abstract][Full Text] [Related]
20. Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy.
Dearling JL; Qureshi U; Begent RH; Pedley RB
Clin Cancer Res; 2007 Mar; 13(6):1903-10. PubMed ID: 17363547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
